Journal articles
Zhang S; Cooper-Knock J; Weimer AK; Shi M; Moll T; Marshall JNG; Harvey C; Nezhad HG; Franklin J; Souza CDS; Ning K; Wang C; Li J; Dilliott AA; Farhan S; Elhaik E; Pasniceanu I; Livesey MR; Eitan C; Hornstein E; Kenna KP; Blair I; Wray NR; Kiernan M; Mitne Neto M; Chio A; Cauchi R; Robberecht W; van Damme P; Corcia P; Couratier P; Hardiman O; McLaughin R; Gotkine M; Drory V; Ticozzi N; Silani V; Veldink JH; van den Berg LH; de Carvalho M; Mora Pardina JS; Povedano M; Andersen P; Weber M; Başak NA; Al-Chalabi A; Shaw C; Shaw PJ; Morrison KE; Landers JE; Glass JD; Ferraiuolo L; Snyder MP, 2022, 'Genome-wide identification of the genetic basis of amyotrophic lateral sclerosis', Neuron, 110, pp. 992 - 1008.e11, http://dx.doi.org/10.1016/j.neuron.2021.12.019
D'Souza A; Wang C; Tu S; Soligo DJ; Kiernan MC; Barnett M; Calamante F, 2022, 'A robust framework for characterising diffusion metrics of the median and ulnar nerves: Exploiting state-of-the-art tracking methods', Journal of the Peripheral Nervous System, 27, pp. 67 - 83, http://dx.doi.org/10.1111/jns.12478
van Rheenen W; van der Spek RAA; Bakker MK; van Vugt JJFA; Hop PJ; Zwamborn RAJ; de Klein N; Westra HJ; Bakker OB; Deelen P; Shireby G; Hannon E; Moisse M; Baird D; Restuadi R; Dolzhenko E; Dekker AM; Gawor K; Westeneng HJ; Tazelaar GHP; van Eijk KR; Kooyman M; Byrne RP; Doherty M; Heverin M; Al Khleifat A; Iacoangeli A; Shatunov A; Ticozzi N; Cooper-Knock J; Smith BN; Gromicho M; Chandran S; Pal S; Morrison KE; Shaw PJ; Hardy J; Orrell RW; Sendtner M; Meyer T; Başak N; van der Kooi AJ; Ratti A; Fogh I; Gellera C; Lauria G; Corti S; Cereda C; Sproviero D; D’Alfonso S; Sorarù G; Siciliano G; Filosto M; Padovani A; Chiò A; Calvo A; Moglia C; Brunetti M; Canosa A; Grassano M; Beghi E; Pupillo E; Logroscino G; Nefussy B; Osmanovic A; Nordin A; Lerner Y; Zabari M; Gotkine M; Baloh RH; Bell S; Vourc’h P; Corcia P; Couratier P; Millecamps S; Meininger V; Salachas F; Mora Pardina JS; Assialioui A; Rojas-García R; Dion PA; Ross JP; Ludolph AC; Weishaupt JH; Brenner D; Freischmidt A; Bensimon G; Brice A; Durr A; Payan CAM; Saker-Delye S; Wood NW; Topp S; Rademakers R; Tittmann L; Lieb W; Franke A; Ripke S; Braun A; Kraft J, 2022, 'Author Correction: Common and rare variant association analyses in amyotrophic lateral sclerosis identify 15 risk loci with distinct genetic architectures and neuron-specific biology (Nature Genetics, (2021), 53, 12, (1636-1648), 10.1038/s41588-021-00973-1)', Nature Genetics, 54, pp. 361 - 361, http://dx.doi.org/10.1038/s41588-022-01020-3
Bocchetta M; Todd EG; Tse NY; Devenney EM; Tu S; Caga J; Hodges JR; Halliday GM; Irish M; Piguet O; Kiernan MC; Rohrer JD; Ahmed RM, 2022, 'Thalamic and Cerebellar Regional Involvement across the ALS–FTD Spectrum and the Effect of C9orf72', Brain Sciences, 12, http://dx.doi.org/10.3390/brainsci12030336
Hop PJ; Zwamborn RAJ; Hannon E; Shireby GL; Nabais MF; Walker EM; van Rheenen W; van Vugt JJFA; Dekker AM; Westeneng HJ; Tazelaar GHP; van Eijk KR; Moisse M; Baird D; Al Khleifat A; Iacoangeli A; Ticozzi N; Ratti A; Cooper-Knock J; Morrison KE; Shaw PJ; Basak AN; Chiò A; Calvo A; Moglia C; Canosa A; Brunetti M; Grassano M; Gotkine M; Lerner Y; Zabari M; Vourc'H P; Corcia P; Couratier P; Mora Pardina JS; Salas T; Dion P; Ross JP; Henderson RD; Mathers S; McCombe PA; Needham M; Nicholson G; Rowe DB; Pamphlett R; Mather KA; Sachdev PS; Furlong S; Garton FC; Henders AK; Lin T; Ngo ST; Steyn FJ; Wallace L; Williams KL; Neto MM; Cauchi RJ; Blair IP; Kiernan MC; Drory V; Povedano M; de Carvalho M; Pinto S; Weber M; Rouleau GA; Silani V; Landers JE; Shaw CE; Andersen PM; McRae AF; van Es MA; Pasterkamp RJ; Wray NR; McLaughlin RL; Hardiman O; Kenna KP; Tsai E; Runz H; Al-Chalabi A; van den Berg LH; Van Damme P; Mill J; Veldink JH; Heijmans BT; t Hoen PAC; van Meurs J; Jansen R; Franke L; Boomsma DI; Pool R; van Dongen J; Hottenga JJ; van Greevenbroek MMJ; Stehouwer CDA; van der Kallen CJH; Schalkwijk CG; Wijmenga C; Zhernakova S; Tigchelaar EF; Slagboom PE, 2022, 'Genome-wide study of DNA methylation shows alterations in metabolic, inflammatory, and cholesterol pathways in ALS', Science Translational Medicine, 14, http://dx.doi.org/10.1126/scitranslmed.abj0264
Perez-Siles G; Ellis M; Ashe A; Grosz B; Vucic S; Kiernan MC; Morris KA; Reddel SW; Kennerson ML, 2022, 'A Compound Heterozygous Mutation in Calpain 1 Identifies a New Genetic Cause for Spinal Muscular Atrophy Type 4 (SMA4)', Frontiers in Genetics, 12, http://dx.doi.org/10.3389/fgene.2021.801253
Vucic S; Wray N; Henders A; Henderson RD; Talman P; Mathers S; Bellgard M; Aoun S; Birks C; Thomas G; Hansen C; Thomas G; Hogden A; Needham M; Schultz D; Soulis T; Sheean B; Milne J; Rowe D; Zoing M; Kiernan MC, 2022, 'MiNDAUS partnership: a roadmap for the cure and management of motor Neurone disease', Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration, 23, pp. 321 - 328, http://dx.doi.org/10.1080/21678421.2021.1980889
Carroll A; Dyck PJ; de Carvalho M; Kennerson M; Reilly MM; Kiernan MC; Vucic S, 2022, 'Novel approaches to diagnosis and management of hereditary transthyretin amyloidosis', Journal of Neurology, Neurosurgery and Psychiatry, 93, pp. 668 - 678, http://dx.doi.org/10.1136/jnnp-2021-327909
Silsby M; Yiannikas C; Ng K; Kiernan MC; Fung VSC; Vucic S, 2022, 'Posturography as a biomarker of intravenous immunoglobulin efficacy in chronic inflammatory demyelinating polyradiculoneuropathy', Muscle and Nerve, 65, pp. 43 - 50, http://dx.doi.org/10.1002/mus.27398
Ashhurst JF; Tu S; Timmins HC; Kiernan MC, 2022, 'Progress, development, and challenges in amyotrophic lateral sclerosis clinical trials', Expert Review of Neurotherapeutics, 22, pp. 905 - 913, http://dx.doi.org/10.1080/14737175.2022.2161893
Lin C; Li T; Tu S; Park S; Vucic S; Kiernan M, 2022, 'TH-265. Evidence of sensory and fine motor dysfunction in peripheral and central nervous systems in Kennedy’s disease (KD)', Clinical Neurophysiology, 141, pp. S171 - S171, http://dx.doi.org/10.1016/j.clinph.2022.07.451
Caga J; Tu S; Dharmadasa T; Tse NY; Zoing MC; Huynh W; Mahoney C; Ahmed RM; Kiernan MC, 2021, 'Apathy is associated with parietal cortical-subcortical dysfunction in ALS', Cortex, 145, pp. 341 - 349, http://dx.doi.org/10.1016/j.cortex.2021.02.029
van Rheenen W; van der Spek RAA; Bakker MK; van Vugt JJFA; Hop PJ; Zwamborn RAJ; de Klein N; Westra HJ; Bakker OB; Deelen P; Shireby G; Hannon E; Moisse M; Baird D; Restuadi R; Dolzhenko E; Dekker AM; Gawor K; Westeneng HJ; Tazelaar GHP; van Eijk KR; Kooyman M; Byrne RP; Doherty M; Heverin M; Al Khleifat A; Iacoangeli A; Shatunov A; Ticozzi N; Cooper-Knock J; Smith BN; Gromicho M; Chandran S; Pal S; Morrison KE; Shaw PJ; Hardy J; Orrell RW; Sendtner M; Meyer T; Başak N; van der Kooi AJ; Ratti A; Fogh I; Gellera C; Lauria G; Corti S; Cereda C; Sproviero D; D’Alfonso S; Sorarù G; Siciliano G; Filosto M; Padovani A; Chiò A; Calvo A; Moglia C; Brunetti M; Canosa A; Grassano M; Beghi E; Pupillo E; Logroscino G; Nefussy B; Osmanovic A; Nordin A; Lerner Y; Zabari M; Gotkine M; Baloh RH; Bell S; Vourc’h P; Corcia P; Couratier P; Millecamps S; Meininger V; Salachas F; Mora Pardina JS; Assialioui A; Rojas-García R; Dion PA; Ross JP; Ludolph AC; Weishaupt JH; Brenner D; Freischmidt A; Bensimon G; Brice A; Durr A; Payan CAM; Saker-Delye S; Wood NW; Topp S; Rademakers R; Tittmann L; Lieb W; Franke A; Ripke S; Braun A; Kraft J, 2021, 'Common and rare variant association analyses in amyotrophic lateral sclerosis identify 15 risk loci with distinct genetic architectures and neuron-specific biology', Nature Genetics, 53, pp. 1636 - 1648, http://dx.doi.org/10.1038/s41588-021-00973-1
Gabery S; Ahmed RM; Caga J; Kiernan MC; Halliday GM; Petersén Å, 2021, 'Loss of the metabolism and sleep regulating neuronal populations expressing orexin and oxytocin in the hypothalamus in amyotrophic lateral sclerosis', Neuropathology and Applied Neurobiology, 47, pp. 979 - 989, http://dx.doi.org/10.1111/nan.12709
Agarwal S; Highton-Williamson E; Caga J; Howells J; Dharmadasa T; Matamala JM; Ma Y; Shibuya K; Hodges JR; Ahmed RM; Vucic S; Kiernan MC, 2021, 'Motor cortical excitability predicts cognitive phenotypes in amyotrophic lateral sclerosis', Scientific Reports, 11, http://dx.doi.org/10.1038/s41598-021-81612-x
Phan K; He Y; Fu YH; Dzamko N; Bhatia S; Gold J; Rowe D; Ke YD; Ittner LM; Hodges JR; Piguet O; Kiernan MC; Halliday GM; Kim WS, 2021, 'Pathological manifestation of human endogenous retrovirus K in frontotemporal dementia', Communications Medicine, 1, http://dx.doi.org/10.1038/s43856-021-00060-w
Kiernan MC, 2021, 'The end of the affair?', Journal of Neurology, Neurosurgery and Psychiatry, 92, pp. 1249 - 1250, http://dx.doi.org/10.1136/jnnp-2021-328176
Devenney EM; McErlean K; Tse NY; Caga J; Dharmadasa T; Huynh W; Mahoney CJ; Zoing M; Mazumder S; Dobson-Stone C; Kwok JB; Halliday GM; Hodges JR; Piguet O; Ahmed RM; Kiernan MC, 2021, 'Factors That Influence Non-Motor Impairment Across the ALS-FTD Spectrum: Impact of Phenotype, Sex, Age, Onset and Disease Stage', Frontiers in Neurology, 12, http://dx.doi.org/10.3389/fneur.2021.743688
Vucic S; Ferguson TA; Cummings C; Hotchkin MT; Genge A; Glanzman R; Roet KCD; Cudkowicz M; Kiernan MC, 2021, 'Gold Coast diagnostic criteria: Implications for ALS diagnosis and clinical trial enrollment', Muscle and Nerve, 64, pp. 532 - 537, http://dx.doi.org/10.1002/mus.27392
Sommer C; Carroll AS; Koike H; Katsuno M; Ort N; Sobue G; Vucic S; Spies JM; Doppler K; Kiernan MC, 2021, 'Nerve biopsy in acquired neuropathies', Journal of the Peripheral Nervous System, 26, pp. S21 - S41, http://dx.doi.org/10.1111/jns.12464
Li T; Mizrahi D; Goldstein D; Kiernan MC; Park SB, 2021, 'Chemotherapy and peripheral neuropathy', Neurological Sciences, 42, pp. 4109 - 4121, http://dx.doi.org/10.1007/s10072-021-05576-6
Di Lazzaro V; Bella R; Benussi A; Bologna M; Borroni B; Capone F; Chen KHS; Chen R; Chistyakov AV; Classen J; Kiernan MC; Koch G; Lanza G; Lefaucheur JP; Matsumoto H; Nguyen JP; Orth M; Pascual-Leone A; Rektorova I; Simko P; Taylor JP; Tremblay S; Ugawa Y; Dubbioso R; Ranieri F, 2021, 'Diagnostic contribution and therapeutic perspectives of transcranial magnetic stimulation in dementia', Clinical Neurophysiology, 132, pp. 2568 - 2607, http://dx.doi.org/10.1016/j.clinph.2021.05.035
Vucic S; Henderson RD; Mathers S; Needham M; Schultz D; Kiernan MC; Mekhael L; Ryder J; Orden B; Menon P; Pavey N; Higashihara M; Dharmadasa T; Huynh W; Ramsey E; Zoing M; Mazumder S; Thornton N; Hall LA; Allcroft P; Toubia M; Hopkins S, 2021, 'Safety and efficacy of dimethyl fumarate in ALS: randomised controlled study', Annals of Clinical and Translational Neurology, 8, pp. 1991 - 1999, http://dx.doi.org/10.1002/acn3.51446
Cudkowicz M; Genge A; Maragakis N; Petri S; van den Berg L; Aho VV; Sarapohja T; Kuoppamäki M; Garratt C; Al-Chalabi A; Kiernan M; Mathers S; Henderson R; Needham M; Schultz D; Löscher W; Mitrovic N; Rath J; Damme PV; De Bleecker JL; Delstanche S; Johnston W; Zinman L; O'Connell C; Matte G; Dionne A; Korngut L; Turnbull J; Laaksovirta H; Jokela M; Tapiola T; Soriani MH; Couratier P; Camu W; Corcia P; Ludolph A; Großkreutz J; Meyer T; Boentert M; Schrank B; Prudlo J; Untucht R; Hardiman O; Siciliano G; Chio' A; Mazzini L; Inghilleri M; Caponnetto C; Mora G; Mora Pardina JS; Farrero Munoz E; Vázquez Costa JF; Aguera Morales E; Varona L; Andersen P; Ingre C; Johansson R; Radunovic A; Young C; Babu S; Shaibani A; Staff N; Vu T; Rivner M; Scelsa S; Sivakumar K; Waheed W; Heitzman D; Rana S; Pattee G; Ajroud-Driss S; Bayat E; Kasarskis E; Lange DJ; Elliott M; Harris B; Felice K; Pulley MT; Kwan J; Brown M; Ravits J; Burford M; Karam C; Miller T; Andrews J; Levine T; Locatelli E; Wymer J; Bedlack R; Fee D; Goyal N; Oskarsson B; McCluskey L; Caress J; Weiss M; Quick A; Bromberg M; Lacomis D; Goutman S; Rezania K, 2021, 'Safety and efficacy of oral levosimendan in people with amyotrophic lateral sclerosis (the REFALS study): a randomised, double-blind, placebo-controlled phase 3 trial', The Lancet Neurology, 20, pp. 821 - 831, http://dx.doi.org/10.1016/S1474-4422(21)00242-8
Caga J; Devenney E; Huynh W; Zoing MC; Ahmed RM; Kiernan MC, 2021, 'Illness Cognitions in ALS: New Insights Into Clinical Management of Behavioural Symptoms', Frontiers in Neurology, 12, http://dx.doi.org/10.3389/fneur.2021.740693
Kang A; Arnold R; Gallagher M; Snelling P; Green J; Fernando M; Kiernan MC; Hand S; Grimley K; Burman J; Heath A; Rogers K; Bhattacharya A; Smyth B; Bradbury T; Hawley C; Perkovic V; Krishnan AV; Jardine MJ, 2021, 'Effect of hemodiafiltration on the progression of neuropathy with kidney failure: A randomized controlled trial', Clinical Journal of the American Society of Nephrology, 16, pp. 1365 - 1375, http://dx.doi.org/10.2215/CJN.17151120
Suzuki YI; Ma Y; Shibuya K; Misawa S; Suichi T; Tsuneyama A; Nakamura K; Matamala JM; Dharmadasa T; Vucic S; Fan D; Kiernan MC; Kuwabara S, 2021, 'Effect of racial background on motor cortical function as measured by threshold tracking transcranial magnetic stimulation', Journal of Neurophysiology, 126, pp. 840 - 844, http://dx.doi.org/10.1152/jn.00083.2021
Vucic S; Pavey N; Haidar M; Turner BJ; Kiernan MC, 2021, 'Cortical hyperexcitability: Diagnostic and pathogenic biomarker of ALS', Neuroscience Letters, 759, http://dx.doi.org/10.1016/j.neulet.2021.136039
McManus L; Lowery M; Merletti R; Søgaard K; Besomi M; Clancy EA; van Dieën JH; Hug F; Wrigley T; Besier T; Carson RG; Disselhorst-Klug C; Enoka RM; Falla D; Farina D; Gandevia S; Holobar A; Kiernan MC; McGill K; Perreault E; Rothwell JC; Tucker K; Hodges PW, 2021, 'Consensus for experimental design in electromyography (CEDE) project: Terminology matrix', Journal of Electromyography and Kinesiology, 59, http://dx.doi.org/10.1016/j.jelekin.2021.102565
Nathani D; Spies J; Barnett MH; Pollard J; Wang MX; Sommer C; Kiernan MC, 2021, 'Nerve biopsy: Current indications and decision tools', Muscle and Nerve, 64, pp. 125 - 139, http://dx.doi.org/10.1002/mus.27201
Devenney EM; Tu S; Caga J; Ahmed RM; Ramsey E; Zoing M; Kwok J; Halliday GM; Piguet O; Hodges JR; Kiernan MC, 2021, 'Neural mechanisms of psychosis vulnerability and perceptual abnormalities in the ALS-FTD spectrum', Annals of Clinical and Translational Neurology, 8, pp. 1576 - 1591, http://dx.doi.org/10.1002/acn3.51363
Kiernan MC, 2021, 'Neurology and clinical neurophysiology: An artificial divide', Practical Neurology, 21, pp. 274 - 275, http://dx.doi.org/10.1136/practneurol-2021-002946
Tu S; Huang M; Caga J; Mahoney CJ; Kiernan MC, 2021, 'Brainstem Correlates of Pathological Laughter and Crying Frequency in ALS', Frontiers in Neurology, 12, http://dx.doi.org/10.3389/fneur.2021.704059
Forrest SL; Kim JH; De Sousa C; Cheong R; Crockford DR; Sheedy D; Stevens J; McCrossin T; Tan RH; McCann H; Shepherd CE; Rowe DB; Kiernan MC; Halliday GM; Kril JJ, 2021, 'Coexisting Lewy body disease and clinical parkinsonism in amyotrophic lateral sclerosis', European Journal of Neurology, 28, pp. 2192 - 2199, http://dx.doi.org/10.1111/ene.14849
Fifita JA; Chan Moi Fat S; McCann EP; Williams KL; Twine NA; Bauer DC; Rowe DB; Pamphlett R; Kiernan MC; Tan VX; Blair IP; Guillemin GJ, 2021, 'Genetic Analysis of Tryptophan Metabolism Genes in Sporadic Amyotrophic Lateral Sclerosis', Frontiers in Immunology, 12, http://dx.doi.org/10.3389/fimmu.2021.701550
Ahmed RM; Kiernan MC, 2021, 'Author Response: Phenotypic Variability in ALS-FTD and Effect on Survival', Neurology, 96, pp. 1103 - 1104, http://dx.doi.org/10.1212/WNL.0000000000012073
Nguyen C; Caga J; Mahoney CJ; Kiernan MC; Huynh W, 2021, 'Behavioural changes predict poorer survival in amyotrophic lateral sclerosis', Brain and Cognition, 150, http://dx.doi.org/10.1016/j.bandc.2021.105710
Ahmed RM; Tse NY; Chen Y; Henning E; Hodges JR; Kiernan MC; Irish M; Farooqi IS; Piguet O, 2021, 'Neural correlates of fat preference in frontotemporal dementia: translating insights from the obesity literature', Annals of Clinical and Translational Neurology, 8, pp. 1318 - 1329, http://dx.doi.org/10.1002/acn3.51369
Hannaford A; Pavey N; van den Bos M; Geevasinga N; Menon P; Shefner JM; Kiernan MC; Vucic S, 2021, 'Diagnostic Utility of Gold Coast Criteria in Amyotrophic Lateral Sclerosis', Annals of Neurology, 89, pp. 979 - 986, http://dx.doi.org/10.1002/ana.26045
Chan Moi Fat S; McCann EP; Williams KL; Henden L; Twine NA; Bauer DC; Pamphlett R; Kiernan MC; Rowe DB; Nicholson GA; Fifita JA; Blair IP, 2021, 'Genetic analysis of GLT8D1 and ARPP21 in Australian familial and sporadic amyotrophic lateral sclerosis', Neurobiology of Aging, 101, pp. 297.e9 - 297.e11, http://dx.doi.org/10.1016/j.neurobiolaging.2021.01.005
Mahoney CJ; Ahmed RM; Huynh W; Tu S; Rohrer JD; Bedlack RS; Hardiman O; Kiernan MC, 2021, 'Pathophysiology and Treatment of Non-motor Dysfunction in Amyotrophic Lateral Sclerosis', CNS Drugs, 35, pp. 483 - 505, http://dx.doi.org/10.1007/s40263-021-00820-1
Timmins HC; Li T; Trinh T; Kiernan MC; Harrison M; Boyle F; Friedlander M; Goldstein D; Park SB, 2021, 'Weekly Paclitaxel-Induced Neurotoxicity in Breast Cancer: Outcomes and Dose Response', Oncologist, 26, pp. 366 - 374, http://dx.doi.org/10.1002/onco.13697
Higashihara M; Pavey N; Van Den Bos M; Menon P; Kiernan MC; Vucic S, 2021, 'Association of Cortical Hyperexcitability and Cognitive Impairment in Patients With Amyotrophic Lateral Sclerosis', Neurology, 96, pp. E2090 - E2097, http://dx.doi.org/10.1212/WNL.0000000000011798
Garcia-Montojo M; Fathi S; Norato G; Smith BR; Rowe DB; Kiernan MC; Vucic S; Mathers S; van Eijk RPA; Santamaria U; Rogers ML; Malaspina A; Lombardi V; Mehta PR; Westeneng HJ; van den Berg LH; Al-Chalabi A; Gold J; Nath A, 2021, 'Inhibition of HERV-K (HML-2) in amyotrophic lateral sclerosis patients on antiretroviral therapy', Journal of the Neurological Sciences, 423, http://dx.doi.org/10.1016/j.jns.2021.117358
Huynh W; Tu S; Mahoney CJ; Schwartz R; Kiernan MC, 2021, 'Mills Syndrome: Clinical and Radiologic Asymmetry', Neurology, 96, pp. 677 - 678, http://dx.doi.org/10.1212/WNL.0000000000011710
van den Bos MAJ; Higashihara M; Geevasinga N; Menon P; Kiernan MC; Vucic S, 2021, 'Pathophysiological associations of transcallosal dysfunction in ALS', European Journal of Neurology, 28, pp. 1172 - 1180, http://dx.doi.org/10.1111/ene.14653
El-Wahsh S; Finger EC; Piguet O; Mok V; Rohrer JD; Kiernan MC; Ahmed RM, 2021, 'Predictors of survival in frontotemporal lobar degeneration syndromes', Journal of Neurology, Neurosurgery and Psychiatry, 92, pp. 425 - 433, http://dx.doi.org/10.1136/jnnp-2020-324349
Weiss MD; Macklin EA; McIlduff CE; Vucic S; Wainger BJ; Kiernan MC; Goutman SA; Goyal NA; Rutkove SB; Ladha SS; Chen IHA; Harms MB; Brannagan TH; Lacomis D; Zivkovic S; Ma M; Wang LH; Simmons Z; Rivner MH; Shefner JM; Cudkowicz ME; Atassi N, 2021, 'Effects of mexiletine on hyperexcitability in sporadic amyotrophic lateral sclerosis: Preliminary findings from a small phase II randomized controlled trial', Muscle and Nerve, 63, pp. 371 - 383, http://dx.doi.org/10.1002/mus.27146
Wainger BJ; Macklin EA; Vucic S; McIlduff CE; Paganoni S; Maragakis NJ; Bedlack R; Goyal NA; Rutkove SB; Lange DJ; Rivner MH; Goutman SA; Ladha SS; Mauricio EA; Baloh RH; Simmons Z; Pothier L; Kassis SB; La T; Hall M; Evora A; Klements D; Hurtado A; Pereira JD; Koh J; Celnik PA; Chaudhry V; Gable K; Juel VC; Phielipp N; Marei A; Rosenquist P; Meehan S; Oskarsson B; Lewis RA; Kaur D; Kiskinis E; Woolf CJ; Eggan K; Weiss MD; Berry JD; David WS; Davila-Perez P; Camprodon JA; Pascual-Leone A; Kiernan MC; Shefner JM; Atassi N; Cudkowicz ME, 2021, 'Effect of Ezogabine on Cortical and Spinal Motor Neuron Excitability in Amyotrophic Lateral Sclerosis: A Randomized Clinical Trial', JAMA Neurology, 78, pp. 186 - 196, http://dx.doi.org/10.1001/jamaneurol.2020.4300
McCann EP; Henden L; Fifita JA; Zhang KY; Grima N; Bauer DC; Chan Moi Fat S; Twine NA; Pamphlett R; Kiernan MC; Rowe DB; Williams KL; Blair IP, 2021, 'Evidence for polygenic and oligogenic basis of Australian sporadic amyotrophic lateral sclerosis', Journal of Medical Genetics, 58, pp. 87 - 95, http://dx.doi.org/10.1136/jmedgenet-2020-106866
Back to profile page
https://orcid.org/0000-0001-9054-026X